RxDoctor Payments DataLook up a doctor →

EMFLAZA: payments to doctors

Payments that named EMFLAZA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$413K
Providers
560
Transactions
1,406
Average per transaction
$294

The per-transaction average — $294 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 560 providers the average total is $738, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
PTC Therapeutics, Inc.$413,021100.0%
← All drugs & devices